Novavax, Inc. (NVAX) Social Stream
NOVAVAX INC (NVAX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NVAX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $305 | $200 | $266.2 | $31.95 | 733.18% |
| 2021-12-16 | 6 | $305 | $172 | $260.6 | $31.95 | 715.65% |
| 2021-12-21 | 6 | $305 | $209 | $268 | $31.95 | 738.81% |
| 2022-01-03 | 6 | $315 | $209 | $270 | $31.95 | 745.07% |
| 2022-01-24 | 7 | $315 | $150 | $250 | $31.95 | 682.47% |
| 2022-02-14 | 7 | $315 | $150 | $232 | $31.95 | 626.13% |
| 2022-02-22 | 7 | $315 | $150 | $223.333 | $31.95 | 599.01% |
| 2022-02-28 | 7 | $294 | $150 | $215 | $31.95 | 572.93% |
| 2022-03-02 | 7 | $294 | $150 | $213 | $31.95 | 566.67% |
| 2022-03-03 | 7 | $250 | $150 | $196 | $31.95 | 513.46% |
| 2022-04-19 | 7 | $250 | $150 | $194.666 | $31.95 | 509.28% |
| 2022-05-10 | 7 | $207 | $150 | $186.833 | $31.95 | 484.77% |
| 2022-05-11 | 7 | $207 | $132 | $178.5 | $31.95 | 458.69% |
| 2022-06-03 | 8 | $207 | $35 | $154.857 | $31.95 | 384.69% |
| 2022-06-08 | 8 | $207 | $35 | $151.857 | $31.95 | 375.3% |
| 2022-07-22 | 7 | $207 | $35 | $147.5 | $31.95 | 361.66% |
| 2022-08-09 | 7 | $207 | $35 | $140.833 | $31.95 | 340.79% |
| 2022-08-13 | 7 | $207 | $35 | $125.833 | $31.95 | 293.84% |
The Trend in the Analyst Price Target
Over the past 13 months, NVAX's average price target has gone down $136.17.
NVAX reports an average of 171.9% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-24 | 7 | 315 | 150 | 250.000 | 79.47 | 214.58% |
| 2022-02-22 | 7 | 315 | 150 | 223.333 | 79.39 | 181.31% |
| 2022-04-19 | 7 | 250 | 150 | 194.666 | 54.59 | 256.6% |
| 2022-04-26 | 7 | 207 | 150 | 186.833 | 47.42 | 294% |
| 2022-05-20 | 8 | 207 | 35 | 154.857 | 53.42 | 189.89% |
NVAX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 4 | 0 | 2 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 92 days, NVAX's average broker recommendation rating worsened by 0.12.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVAX as an investment opportunity.
- In the context of all US stocks, NOVAVAX INC's upside potential (average analyst target price relative to current price) is greater than 1964.89% of them.
- In the context of all US stocks, NOVAVAX INC's average analyst price target is higher than 1856.52% of them.
- In terms of how NOVAVAX INC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 305.34% of that group.
- To contextualize these metrics, consider that out of stocks in the large market cap category, NOVAVAX INC's variance in analysts' estimates is lower than -1339.02% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NOVAVAX INC are NBIX, MRNA, and GILD.
View All Top Stocks by Price Target
Is NVAX a Buy, Hold or Sell? See the POWR Ratings now!